AstraZeneca and Neurimmune ink $760 million deal for antibody drug Reuters Mar 3, 2022 Under the agreement, Alexion would pay Neurimmune an upfront payment of $30 million and it would be eligible for payments of up to…
AstraZeneca to acquire Alexion EP News Bureau Dec 12, 2020 Subject to approvals, the acquisition is expected to close in Q3 2021
Lonza announces additional long-term agreement with Alexion Usha Sharma Jul 2, 2015 This agreement will supplement existing production of Alexion products at multiple Lonza facilities
